Exploring limitations in the current standard of care for thyroid hormone replacement therapy in thyroid cancer survivors
Summary
We are asking thyroid cancer survivors who are currently undergoing treatment for their post-thyroidectomy care to answer a short survey about their care experiences, some related symptom management, and a few questions about how they work with their doctors.
Eligibility
Eligible gender: Male, Female, Transgender, Other
Eligible ages: 18 to 111
Accepts healthy participants: Yes
Inclusion criteria:
- 18 years or older
- partial or total removal of thyroid gland (thyroidectomy) for the treatment of thyroid cancer
- now require treatment with any kind of thyroid hormone replacement medication (e.g., Synthroid, desiccated thyroid extract, liothyronine, levothyroxine, or any combination therapy)
Exclusion criteria:
- Less than 18 years old
- Anyone who has not had some or all of their thyroid gland removed
- Not on any thyroid medication (e.g., Synthroid, desiccated thyroid extract, liothyronine, levothyroxine, or any combination therapy)
Participate
Fill out the following form if you want to participate in this research
Collection of personal information
Your personal information is collected under
the authority of section 33(c) of the Freedom of Information and Protection of Privacy Act. If
you have any questions about the collection or use of this information, please visit our
Access to Information page.
Additional information
Contact information
Email julie.babione@ucalgary.ca or leave a message at 403-210-7389 for more information.
Principal investigator:
Sana Ghaznavi
Clinical trial:
No
REB-ID:
HREBA.CC-23-0125